Aurora Cannabis falls short of revenue target and stock drops
By Steve Gelsi
Revenue rises 5% to C$67.4 million but misses C$69.5 million analyst estimate.
Aurora Cannabis Inc.'s stock fell nearly 6% on Thursday after the Canadian marijuana company fell short of the analyst estimate for its fourth-quarter revenue, although it reported a narrower loss than in the previous year on robust international business.
Aurora Cannabis (ACB) said it lost C$20.8 million ($15.17 million) in its fiscal fourth quarter, compared to a loss of C$76.2 million in the year-ago quarter.
The company did not provide figures for loss per share. Revenue rose by 5% to C$67.4 million, below the FactSet consensus estimate of C$69.5 million.
Medical cannabis net revenue rose 20% to C$45.6 million, due mostly to higher sales to Australia and Europe following the launch of cultivars in those markets.
Aurora's consumer cannabis net revenue fell to C$10.2 million from C$14.5 million as the company prioritized supply to higher-margin international business.
Chief Executive Miguel Martin said 2024 marked the strongest fiscal year ever for Aurora Cannabis with a 21% increase in annual revenue.
The company reported its first annualized adjusted earnings before interest, taxes, depreciation and amortization in 2024 of C$12.8 million.
"We also strengthened our balance sheet...and fully repaid our convertible debt," Martin said.
The company said it ended the year with C$180 million in cash.
Prior to Thursday's moves, Aurora's stock was up 20% in 2024, compared to a 19% rise by the Nasdaq COMP.
-Steve Gelsi
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
06-20-24 1034ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
Markets Brief: Non-Farm Payrolls in the Spotlight Again
-
6 Top-Performing Large-Growth Funds
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
Morningstar’s Guide to Investing in Stocks
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst